| Clinical epidemiology and disease burden of nonalcoholic fatty liver disease BJ Perumpail, MA Khan, ER Yoo, G Cholankeril, D Kim, A Ahmed World journal of gastroenterology 23 (47), 8263, 2017 | 783 | 2017 |
| High prevalence of concurrent gastrointestinal manifestations in patients with SARS-CoV-2: early experience from California G Cholankeril, A Podboy, VI Aivaliotis, B Tarlow, EA Pham, S Spencer, ... Gastroenterology 159 (2), 775-777, 2020 | 263* | 2020 |
| Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes G Cholankeril, RJ Wong, M Hu, RB Perumpail, ER Yoo, P Puri, ... Digestive diseases and sciences 62, 2915-2922, 2017 | 245 | 2017 |
| Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States G Cholankeril, A Ahmed Clinical gastroenterology and hepatology: the official clinical practice …, 2018 | 240 | 2018 |
| Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management G Cholankeril, R Patel, S Khurana, SK Satapathy World journal of hepatology 9 (11), 533, 2017 | 214 | 2017 |
| Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016 D Kim, AA Li, C Gadiparthi, MA Khan, G Cholankeril, JS Glenn, A Ahmed Gastroenterology 155 (4), 1154-1163. e3, 2018 | 213 | 2018 |
| Changing trends in etiology‐based and ethnicity‐based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States D Kim, AA Li, BJ Perumpail, C Gadiparthi, W Kim, G Cholankeril, JS Glenn, ... Hepatology 69 (3), 1064-1074, 2019 | 182 | 2019 |
| Impact of COVID‐19 pandemic on liver transplantation and alcohol‐associated liver disease in the USA G Cholankeril, K Goli, A Rana, R Hernaez, A Podboy, P Jalal, BL Da, ... Hepatology 74 (6), 3316-3329, 2021 | 180 | 2021 |
| The Role of Vitamin E in the Treatment of NAFLD BJ Perumpail, AA Li, N John, S Sallam, ND Shah, W Kwong, ... Diseases 6 (4), 86, 2018 | 120 | 2018 |
| Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis S Kamal, MA Khan, A Seth, G Cholankeril, D Gupta, U Singh, F Kamal, ... Official journal of the American College of Gastroenterology| ACG 112 (10 …, 2017 | 104 | 2017 |
| Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease D Kim, LM Vazquez‐Montesino, AA Li, G Cholankeril, A Ahmed Hepatology 72 (5), 1556-1568, 2020 | 94 | 2020 |
| Early impact of COVID-19 on solid organ transplantation in the United States G Cholankeril, A Podboy, OS Alshuwaykh, D Kim, F Kanwal, CO Esquivel, ... Transplantation 104 (11), 2221-2224, 2020 | 83 | 2020 |
| The importance of a multidisciplinary approach to hepatocellular carcinoma O Siddique, ER Yoo, RB Perumpail, BJ Perumpail, A Liu, G Cholankeril, ... Journal of Multidisciplinary Healthcare, 95-100, 2017 | 80 | 2017 |
| Depression is associated with non‐alcoholic fatty liver disease among adults in the United States D Kim, ER Yoo, AA Li, SP Tighe, G Cholankeril, SA Harrison, A Ahmed Alimentary pharmacology & therapeutics 50 (5), 590-598, 2019 | 78 | 2019 |
| Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005–2016 D Kim, W Kim, AC Adejumo, G Cholankeril, SP Tighe, RJ Wong, ... Hepatology international 13, 205-213, 2019 | 73 | 2019 |
| Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by FibroScan D Kim, P Konyn, G Cholankeril, A Ahmed Clinical Gastroenterology and Hepatology 20 (6), e1438-e1455, 2022 | 67 | 2022 |
| Trends in mortality from extrahepatic complications in patients with chronic liver disease, from 2007 through 2017 D Kim, AC Adejumo, ER Yoo, U Iqbal, AA Li, EA Pham, G Cholankeril, ... Gastroenterology 157 (4), 1055-1066. e11, 2019 | 64 | 2019 |
| Association of digestive symptoms and hospitalization in patients with SARS-CoV-2 infection G Cholankeril, A Podboy, VI Aivaliotis, EA Pham, SP Spencer, D Kim, ... Official journal of the American College of Gastroenterology| ACG 115 (7 …, 2020 | 57 | 2020 |
| Physical activity, measured objectively, is associated with lower mortality in patients with nonalcoholic fatty liver disease D Kim, S Murag, G Cholankeril, A Cheung, SA Harrison, ZM Younossi, ... Clinical Gastroenterology and Hepatology 19 (6), 1240-1247. e5, 2021 | 54 | 2021 |
| Low thyroid function in nonalcoholic fatty liver disease is an independent predictor of all-cause and cardiovascular mortality D Kim, LM Vazquez-Montesino, JA Escober, CT Fernandes, ... Official journal of the American College of Gastroenterology| ACG 115 (9 …, 2020 | 53 | 2020 |
